208 related articles for article (PubMed ID: 29441717)
1. S100A9 gene silencing inhibits the release of pro-inflammatory cytokines by blocking the IL-17 signalling pathway in mice with acute pancreatitis.
Wu DM; Wang S; Shen M; Wang YJ; Zhang B; Wu ZQ; Lu J; Zheng YL
J Cell Mol Med; 2018 Apr; 22(4):2378-2389. PubMed ID: 29441717
[TBL] [Abstract][Full Text] [Related]
2. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
3. Effects of silencing the DUSP1 gene using lentiviral vector-mediated siRNA on the release of proinflammatory cytokines through regulation of the MAPK signaling pathway in mice with acute pancreatitis.
Zhang B; Li SL; Xie HL; Fan JW; Gu CW; Kang C; Teng MJ
Int J Mol Med; 2018 Apr; 41(4):2213-2224. PubMed ID: 29393354
[TBL] [Abstract][Full Text] [Related]
4. S100A9-induced release of interleukin (IL)-6 and IL-8 through toll-like receptor 4 (TLR4) in human periodontal ligament cells.
Gao H; Zhang X; Zheng Y; Peng L; Hou J; Meng H
Mol Immunol; 2015 Oct; 67(2 Pt B):223-32. PubMed ID: 26038301
[TBL] [Abstract][Full Text] [Related]
5. S100A9 induced inflammatory responses are mediated by distinct damage associated molecular patterns (DAMP) receptors in vitro and in vivo.
Chen B; Miller AL; Rebelatto M; Brewah Y; Rowe DC; Clarke L; Czapiga M; Rosenthal K; Imamichi T; Chen Y; Chang CS; Chowdhury PS; Naiman B; Wang Y; Yang D; Humbles AA; Herbst R; Sims GP
PLoS One; 2015; 10(2):e0115828. PubMed ID: 25706559
[TBL] [Abstract][Full Text] [Related]
6. S100A9 Increases IL-6 and RANKL Expressions through MAPKs and STAT3 Signaling Pathways in Osteocyte-Like Cells.
Takagi R; Sakamoto E; Kido JI; Inagaki Y; Hiroshima Y; Naruishi K; Yumoto H
Biomed Res Int; 2020; 2020():7149408. PubMed ID: 32149126
[TBL] [Abstract][Full Text] [Related]
7. Association analysis of high-mobility group box-1 protein 1 (HMGB1)/toll-like receptor (TLR) 4 with nasal interleukins in allergic rhinitis patients.
Zhu X; Cong J; Yang B; Sun Y
Cytokine; 2020 Feb; 126():154880. PubMed ID: 31739216
[TBL] [Abstract][Full Text] [Related]
8. IL-1β/HMGB1 signalling promotes the inflammatory cytokines release via TLR signalling in human intervertebral disc cells.
Fang F; Jiang D
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27512095
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
10. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
[No Abstract] [Full Text] [Related]
11. Blocking the interaction between S100A9 protein and RAGE V domain using S100A12 protein.
Katte R; Yu C
PLoS One; 2018; 13(6):e0198767. PubMed ID: 29902210
[TBL] [Abstract][Full Text] [Related]
12. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
13. Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.
Ullah MA; Loh Z; Gan WJ; Zhang V; Yang H; Li JH; Yamamoto Y; Schmidt AM; Armour CL; Hughes JM; Phipps S; Sukkar MB
J Allergy Clin Immunol; 2014 Aug; 134(2):440-50. PubMed ID: 24506934
[TBL] [Abstract][Full Text] [Related]
14. Modulation of HMGB1 translocation and RAGE/NFκB cascade by quercetin treatment mitigates atopic dermatitis in NC/Nga transgenic mice.
Karuppagounder V; Arumugam S; Thandavarayan RA; Pitchaimani V; Sreedhar R; Afrin R; Harima M; Suzuki H; Nomoto M; Miyashita S; Suzuki K; Nakamura M; Watanabe K
Exp Dermatol; 2015 Jun; 24(6):418-23. PubMed ID: 25739980
[TBL] [Abstract][Full Text] [Related]
15. TLR4-HMGB1 signaling pathway affects the inflammatory reaction of autoimmune myositis by regulating MHC-I.
Wan Z; Zhang X; Peng A; He M; Lei Z; Wang Y
Int Immunopharmacol; 2016 Dec; 41():74-81. PubMed ID: 27816788
[TBL] [Abstract][Full Text] [Related]
16. Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies.
Shen WS; Xu XQ; Zhai NN; Zhou ZS; Shao J; Yu YH
Gene Ther; 2017 Jun; 24(6):353-360. PubMed ID: 28440797
[TBL] [Abstract][Full Text] [Related]
17. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
18. RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells.
Ramya R; Coral K; Bharathidevi SR
Exp Eye Res; 2021 May; 206():108519. PubMed ID: 33639133
[TBL] [Abstract][Full Text] [Related]
19. Interplay between RAGE and TLR4 Regulates HMGB1-Induced Inflammation by Promoting Cell Surface Expression of RAGE and TLR4.
Zhong H; Li X; Zhou S; Jiang P; Liu X; Ouyang M; Nie Y; Chen X; Zhang L; Liu Y; Tao T; Tang J
J Immunol; 2020 Aug; 205(3):767-775. PubMed ID: 32580932
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of S100 calcium binding protein A9 attenuates vascular dysfunction in aged mice.
Zhao B; Yu J; Luo Y; Xie M; Qu C; Shi Q; Wang X; Zhao X; Kong L; Zhao Y; Guo Y
Redox Biol; 2023 Jul; 63():102721. PubMed ID: 37163872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
